The oral LD50 of PEG 3350 in rats is 22000 mg/kg.L11857
There is limited clinical information on the overdose of polyethylene glycols. Based on the pharmacological action of the compound, severe diarrhea may be suspected. Overdose of polyethylene glycols should be responded with symptomatic and supportive care.
Polyethylene glycol (PEG) is a synthetic polymer produced via polymerization of ethylene oxide molecules to make joining units of ethylene glycol by an ether linkage.A190975,A190978 PEGs are water-soluble polymers that can form hydrogen bonds in a ratio of 100 water molecules per one PEG molecule.A190975 Molecular weights of PEGs vary by time of the polymerization process and the molecular weight represents the weighted average of the individual PEG molecules. PEGs differ in their physical and chemical properties depending on their molecular weight: PEGs are liquids when molecular weights are <1000 and the molecule turns to waxy solids with increasing molecular weights.A190978 The most common preparations of PEGs include PEG 3350 and PEG 400. PEGs have various applications in many fields, ranging from medical to industrial areas. PEGs have a long history of gastroenterology: PEG 3350 is a common over-the-counter osmotic laxative used to relieve occasional constipation.L11812 PEG 3350 is also used for cleansing of the colon in preparation for colonoscopy in adults.L6421
The rationale of using PEG in gastroenterology is due to the physical properties of the compound: its potent water-binding capacity, negligible intestinal absorption with increasing molecular mass, lack of significant toxicity, and limited intestinal enzymatic degradation or bacterial metabolism all make PEG a useful therapeutic agent for the treatment of occasional constipation and bowel cleansing for preparation in colonoscopy.A18713
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Peginterferon alfa-2a | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfa-2a. |
| Pegfilgrastim | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegfilgrastim. |
| Peginterferon alfa-2b | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfa-2b. |
| Pegaspargase | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegaspargase. |
| Pegademase | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegademase. |
| Pegvisomant | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegvisomant. |
| Heptaethylene glycol | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Heptaethylene glycol. |
| Pegaptanib | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegaptanib. |
| Egaptivon pegol | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Egaptivon pegol. |
| PEG-uricase | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with PEG-uricase. |
| Peginterferon alfacon-1 | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfacon-1. |
| GlycoPEG-GCSF | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with GlycoPEG-GCSF. |
| Pegnivacogin | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegnivacogin. |
| Pegpleranib | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegpleranib. |
| Pegsunercept | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegsunercept. |
| Polidocanol | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Polidocanol. |
| Peginesatide | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginesatide. |
| Certolizumab pegol | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Certolizumab pegol. |
| Methoxy polyethylene glycol-epoetin beta | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Methoxy polyethylene glycol-epoetin beta. |
| Peginterferon beta-1a | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon beta-1a. |
| Pegloticase | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegloticase. |
| Antihemophilic factor (recombinant), PEGylated | The therapeutic efficacy of Antihemophilic factor (recombinant), PEGylated can be decreased when used in combination with Polyethylene glycol. |
| Insulin peglispro | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Polyethylene glycol. |
| Eptacog alfa pegol (activated) | The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Polyethylene glycol. |
| Olaptesed Pegol | The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Polyethylene glycol. |
| Abicipar Pegol | The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Polyethylene glycol. |
| Lexaptepid pegol | The therapeutic efficacy of Lexaptepid pegol can be decreased when used in combination with Polyethylene glycol. |
| Cepeginterferon alfa-2B | The therapeutic efficacy of Cepeginterferon alfa-2B can be decreased when used in combination with Polyethylene glycol. |
| Pegvaliase | The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Polyethylene glycol. |
| Pegamotecan | The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Polyethylene glycol. |
| Lipegfilgrastim | The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Polyethylene glycol. |
| Nonacog beta pegol | The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Polyethylene glycol. |
| Damoctocog alfa pegol | The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Polyethylene glycol. |
| Elapegademase | The therapeutic efficacy of Elapegademase can be decreased when used in combination with Polyethylene glycol. |
| Digoxin | The serum concentration of Digoxin can be decreased when it is combined with Polyethylene glycol. |
| Metildigoxin | The serum concentration of Metildigoxin can be decreased when it is combined with Polyethylene glycol. |
| Acetyldigoxin | The serum concentration of Acetyldigoxin can be decreased when it is combined with Polyethylene glycol. |
| Trospium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Trospium. |
| Oxyphenonium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Oxyphenonium. |
| Benzatropine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Benzatropine. |
| Ziprasidone | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Ziprasidone. |
| Disopyramide | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Disopyramide. |
| Ipratropium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Ipratropium. |
| Metixene | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Metixene. |
| Buclizine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Buclizine. |
| Doxylamine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Doxylamine. |
| Trihexyphenidyl | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Trihexyphenidyl. |
| Oxyphencyclimine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Oxyphencyclimine. |
| Procyclidine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Procyclidine. |
| Profenamine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Profenamine. |
| Promazine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Promazine. |
| Hyoscyamine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Hyoscyamine. |
| Cyproheptadine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Cyproheptadine. |
| Methscopolamine bromide | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Methscopolamine bromide. |
| Gallamine triethiodide | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Gallamine triethiodide. |
| Darifenacin | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Darifenacin. |
| Tridihexethyl | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Tridihexethyl. |
| Triflupromazine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Triflupromazine. |
| Anisotropine methylbromide | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Anisotropine methylbromide. |
| Nortriptyline | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Nortriptyline. |
| Amoxapine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Amoxapine. |
| Atropine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Atropine. |
| Pirenzepine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pirenzepine. |
| Paroxetine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Paroxetine. |
| Homatropine methylbromide | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Homatropine methylbromide. |
| Rocuronium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Rocuronium. |
| Scopolamine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Scopolamine. |
| Benzquinamide | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Benzquinamide. |
| Clidinium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Clidinium. |
| Propiomazine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Propiomazine. |
| Propantheline | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Propantheline. |
| Dicyclomine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Dicyclomine. |
| Biperiden | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Biperiden. |
| Brompheniramine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Brompheniramine. |
| Cocaine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Cocaine. |
| Maprotiline | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Maprotiline. |
| Methantheline | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Methantheline. |
| Cycrimine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Cycrimine. |
| Glycopyrronium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Glycopyrronium. |
| Tolterodine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Tolterodine. |
| Oxybutynin | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Oxybutynin. |
| Promethazine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Promethazine. |
| Diphenhydramine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Diphenhydramine. |
| Doxacurium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Doxacurium. |
| Flavoxate | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Flavoxate. |
| Desipramine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Desipramine. |
| Orphenadrine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Orphenadrine. |
| Escitalopram | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Escitalopram. |
| Mivacurium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Mivacurium. |
| Diphenidol | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Diphenidol. |
| Aripiprazole | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Aripiprazole. |
| Chlorprothixene | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Chlorprothixene. |
| Metocurine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Metocurine. |
| Pancuronium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pancuronium. |
| Pipecuronium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pipecuronium. |
| Methotrimeprazine | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Methotrimeprazine. |
| Tiotropium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Tiotropium. |
| Solifenacin | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Solifenacin. |
| Isopropamide | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Isopropamide. |
| Rapacuronium | The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Rapacuronium. |